Tutorials
Merck & Co Inc logo

Merck & Co Inc

lei 228.00 (0%) Aug 6
P/E:
13.94
P/B:
5.33
Market Cap:
lei 664.11B ($ 139.49B)
Enterprise V:
lei 766.99B ($ 161.10B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap lei:
664.11B
Market Cap $:
139.49B
PE Ratio:
13.94
Avg Vol (2-Month):
-
Enterprise Value lei:
766.99B
Enterprise Value $:
161.10B
PB Ratio:
5.33
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Merck & Co Inc
NAICS : 325412 SIC : 2834
2000 Galloping Hill Road, Kenilworth, NJ, USA, 07033
Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.32
Equity-to-Asset 0.4
Debt-to-Equity 0.73
Debt-to-EBITDA 1.37
Interest Coverage 21.8
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.17
Distress
Grey
Safe
Beneish M-Score -2.32
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.39
Quick Ratio 1.15
Cash Ratio 0.44
Days Inventory 143.02
Days Sales Outstanding 57.61
Days Payable 82.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Dividend Growth Rate 9.9
3-Year Average Share Buyback Ratio 0.8

Financials (Next Earnings Date:2022-10-27)

BSE:MRK's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil lei) 271,997.468
EPS (TTM) (lei) 0
Beta 0
Volatility % 1.39
14-Day RSI 0
14-Day ATR (lei) 0
20-Day SMA (lei) 0
12-1 Month Momentum % 0
52-Week Range (lei) 228 - 228
Shares Outstanding (Mil) 2,659.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Document Form Filing Date
No Filing Data